BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33804934)

  • 21. Individualized management of follicular lymphoma.
    Bai B; Huang HQ
    Chin Clin Oncol; 2015 Mar; 4(1):7. PubMed ID: 25841714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome.
    Jin MK; Hoster E; Dreyling M; Unterhalt M; Hiddemann W; Klapper W
    Histopathology; 2011 Mar; 58(4):586-92. PubMed ID: 21401698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin's disease and either follicular lymphoma or B-CLL.
    Küppers R; Sousa AB; Baur AS; Strickler JG; Rajewsky K; Hansmann ML
    Mol Med; 2001 May; 7(5):285-92. PubMed ID: 11474574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
    Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
    Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteasome inhibition with bortezomib: a new therapeutic strategy for non-Hodgkin's lymphoma.
    Leonard JP; Furman RR; Coleman M
    Int J Cancer; 2006 Sep; 119(5):971-9. PubMed ID: 16557600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and management of follicular lymphoma: A comprehensive review.
    Dada R
    Eur J Haematol; 2019 Sep; 103(3):152-163. PubMed ID: 31270855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infections and Follicular Lymphoma: is there a Link?
    Zallio F; Limberti G; Ladetto M
    Mediterr J Hematol Infect Dis; 2017; 9(1):e2017035. PubMed ID: 28512564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follicular non-Hodgkin's lymphoma.
    Hayashi D; Lee JC; Devenney-Cakir B; Zaim S; Ounadjela S; Solal-Céligny P; Juweid M; Guermazi A
    Clin Radiol; 2010 May; 65(5):408-20. PubMed ID: 20380942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
    Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological hepatitis B virus (HBV) activity in patients with HBV infection and B-cell non-Hodgkin's lymphoma.
    Zhou X; Wuchter P; Egerer G; Kriegsmann M; Kommoss FKF; Witzens-Harig M; Kriegsmann K
    Eur J Haematol; 2020 May; 104(5):469-475. PubMed ID: 31961011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B virus and risk of non-Hodgkin lymphoma: An updated meta-analysis of 58 studies.
    Li M; Gan Y; Fan C; Yuan H; Zhang X; Shen Y; Wang Q; Meng Z; Xu D; Tu H
    J Viral Hepat; 2018 Aug; 25(8):894-903. PubMed ID: 29532605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.
    Hester LL; Park SI; Wood WA; Stürmer T; Brookhart MA; Lund JL
    Cancer; 2019 Apr; 125(7):1101-1112. PubMed ID: 30548238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reappraising the role of autologous transplantation for indolent B-cell lymphomas in the chemoimmunotherapy era: is it still relevant?
    Hamadani M
    Bone Marrow Transplant; 2013 Aug; 48(8):1013-21. PubMed ID: 23000653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined applications of fine needle aspiration cytology and flow cytometric immunphenotyping for diagnosis and classification of non Hodgkin lymphoma.
    Dey P; Amir T; Al Jassar A; Al Shemmari S; Jogai S; Bhat M G; Al Quallaf A; Al Shammari Z
    Cytojournal; 2006 Oct; 3():24. PubMed ID: 17069647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency of CD43 expression in non-Hodgkin lymphoma. A survey of 742 cases and further characterization of rare CD43+ follicular lymphomas.
    Lai R; Weiss LM; Chang KL; Arber DA
    Am J Clin Pathol; 1999 Apr; 111(4):488-94. PubMed ID: 10191768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-MYC translocation in t(14;18) positive follicular lymphoma at presentation: An adverse prognostic indicator?
    Christie L; Kernohan N; Levison D; Sales M; Cunningham J; Gillespie K; Batstone P; Meiklejohn D; Goodlad J
    Leuk Lymphoma; 2008 Mar; 49(3):470-6. PubMed ID: 18297523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large-scale microarray profiling reveals four stages of immune escape in non-Hodgkin lymphomas.
    Tosolini M; Algans C; Pont F; Ycart B; Fournié JJ
    Oncoimmunology; 2016 Jul; 5(7):e1188246. PubMed ID: 27622044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A high complex karyotype involving eleven chromosomes including three novel chromosomal aberrations and monoallelic loss of
    Wafa A; Moassass F; Liehr T; Bhatt S; Aljapawe A; Al Achkar W
    Mol Cytogenet; 2016; 9():91. PubMed ID: 28031746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis.
    Ferretti E; Di Carlo E; Ognio E; Fraternali-Orcioni G; Corcione A; Belmonte B; Ravetti JL; Tripodo C; Ribatti D; Pistoia V
    Oncoimmunology; 2018; 7(3):e1397249. PubMed ID: 29399397
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.